Skip to main content
Protein Science : A Publication of the Protein Society logoLink to Protein Science : A Publication of the Protein Society
. 2001 Jul;10(7):1353–1362. doi: 10.1110/ps.ps.40101

Aberrant mobility phenomena of the DNA repair protein XPA

Lilia M Iakoucheva 1,4, Amy L Kimzey 1, Christophe D Masselon 2, Richard D Smith 2, A Keith Dunker 3, Eric J Ackerman 1
PMCID: PMC2374115  PMID: 11420437

Abstract

The DNA repair protein XPA recognizes a wide variety of bulky lesions and interacts with several other proteins during nucleotide excision repair. We recently identified regions of intrinsic order and disorder in full length Xenopus XPA (xXPA) protein using an experimental approach that combined time-resolved trypsin proteolysis and electrospray ionization interface coupled to a Fourier transform ion cyclotron resonance (ESI-FTICR) mass spectrometry (MS). MS data were consistent with the interpretation that xXPA contains no post-translational modifications. Here we characterize the discrepancy between the calculated molecular weight (31 kDa) for xXPA and its apparent molecular weight on SDS-PAGE (multiple bands from ∼40–45 kDa) and gel filtration chromatography (∼92 kDa), as well as the consequences of DNA binding on its anomalous mobility. Iodoacetamide treatment of xXPA prior to SDS-PAGE yielded a single 42-kDa band, showing that covalent modification of Cys did not correct aberrant mobility. Determination of sulfhydryl content in xXPA with Ellman's reagent revealed that all nine Cys in active protein are reduced. Unexpectedly, structural constraints induced by intramolecular glutaraldehyde crosslinks in xXPA produced a ∼32-kDa monomer in closer agreement with its calculated molecular weight. To investigate whether binding to DNA alters xXPA's anomalous migration, we used gel filtration chromatography. For the first time, we purified stable complexes of xXPA and DNA ± cisplatin ± mismatches. xXPA showed at least 10-fold higher affinity for cisplatin DNA ± mismatches compared to undamaged DNA ± mismatches. In all cases, DNA binding did not correct xXPA's anomalous migration. To test predictions that a Glu-rich region (EEEEAEE) and/or disordered N- and C-terminal domains were responsible for xXPA's aberrant mobility, the molecular weights of partial proteolytic fragments from ∼5 to 25 kDa separated by reverse-phase HPLC and precisely determined by ESI-FTICR MS were correlated with their migration on SDS-PAGE. Every partial tryptic fragment analyzed within this size range exhibited 10%–50% larger molecular weights than expected. Thus, both the disordered domains and the Glu-rich region in xXPA are primarily responsible for the aberrant mobility phenomena.

Keywords: XPA, ESI-FTICR mass spectrometry, DNA repair, gel electrophoresis, SDS-PAGE, intrinsic disorder, partial proteolysis


Xeroderma pigmentosum group A protein (XPA) is an essential component of nucleotide excision repair (NER) (Friedberg et al. 1995). Although the molecular mechanisms of NER are not well-understood, XPA is involved in DNA damage recognition for a wide variety of bulky lesions, and it interacts with other NER proteins, including RPA, ERCC1, and ERCC4 (Lindahl and Wood 1999). XPA is the only repair protein whose genetic disruption completely obliterates NER (Lindahl and Wood 1999).

We recently performed time-resolved trypsin proteolysis on active, full-length recombinant Xenopus XPA protein (xXPA) to better characterize its structural features (Iakoucheva et al. 2001). Partial proteolytic fragments were analyzed by electrospray ionization interface coupled to Fourier transform ion cyclotron resonance (ESI-FTICR) mass spectrometry (MS) and a novel algorithm designed to predict disorder in proteins. Our results were consistent with the interpretation that about two-thirds of the molecule is flexible or disordered, mostly at the N and C termini. The remainder constitutes an ordered core containing a Zn-finger and approximately corresponding to the minimal binding domain (MBD) of human XPA (hXPA), whose NMR structure is known (Buchko et al. 1998; Ikegami et al. 1998).

Aberrant mobility of XPA under denaturing conditions was reported earlier but not studied in detail. Multiple bands of nearly equal intensity exhibiting anomalously high mobility on SDS-PAGE under reducing conditions in the Laemmli system (Laemmli 1970) were previously observed for hXPA and some of its deletion mutants (Miyamoto et al. 1992; Kuraoka et al. 1996). Here we investigate these migration phenomena for xXPA using gel filtration chromatography, ESI-FTICR MS, and SDS-PAGE. Despite some sequence differences between the human and Xenopus protein (67% amino acid identity), migration abnormalities for XPA are conserved between species. Our objective was to test whether multiple bands and aberrant mobility were caused by a single parameter such as reduced/oxidized sulfhydryls, a highly charged Glu-rich region, the long disordered domains, or a combination thereof. The extreme precision provided by ESI-FTICR MS greatly facilitated assignment of xXPA's fragments to their sequences and mobility. A question that needs to be addressed is whether these parameters correlate with putative structural changes in XPA that may have direct functional consequences in DNA repair.

Disorder-to-order transitions upon DNA or protein binding facilitate shape accommodations so that proteins with significant disordered regions could bind to a wide variety of structurally distinct substrates (Kriwacki et al. 1996; Wright and Dyson 1999). This explanation is consistent with both xXPA's disordered domains and its function to recognize and bind to many different bulky adducts, as well as interact with other DNA repair proteins. Previous reports that used electrophoretic mobility shift assays (EMSA) (Jones and Wood 1993; Lao et al. 2000) or filter-binding assays (Asahina et al. 1994) to study XPA binding to DNA ± various lesions showed a surprisingly low preference for damaged over undamaged DNA despite the high fidelity of NER. Thus, an additional objective of our study was to test whether gel filtration chromatography might complement EMSA and perhaps detect higher preference of xXPA for damaged DNA. First we showed that xXPA–DNA complexes were stable during gel filtration chromatography. We then determined whether xXPA binding to DNA ± lesions caused conformational changes that significantly altered its aberrant migration under native conditions. Finally, we discussed the possible causes of xXPA's migration phenomena.

Results and Discussion

Aberrant mobility on SDS-PAGE and the role of sulfhydryls

Aberrant mobility on SDS-PAGE is well-known for proteins containing post-translational modifications. These include phosphorylation (Billings et al. 1979), glycosylation (Marciani and Papamatheakis 1978), incomplete reduction of disulfide bonds (Dunker and Kenyon 1976), excess positive (Hu and Ghabrial 1995) or negative charge (Armstrong and Roman 1993), and the connection of globular domains by flexible linkers containing atypical amino acid compositions (Fontana et al. 1997). Our mass spectrometry results (Iakoucheva et al. 2001) were consistent with the interpretation that xXPA (Fig. 1) contains no post-translational modifications or any putative disulfides because its molecular weight determined by ESI-FTICR mass spectrometry (30922.02 Da) agreed within 0.43 Da to that calculated from the sequence (30922.45 Da). Nonetheless, its SDS-PAGE mobility was ∼42 kDa, ∼40% larger than expected (Fig. 2A). Furthermore, xXPA usually migrates as 2–4 bands of nearly equal intensity ranging in size from ∼40–45 kDa (Fig. 2A, lane 1). Interactions with Zn were eliminated as a factor in both anomalous migration and multiple bands by pretreatment of xXPA with 100 mM EDTA prior to electrophoresis (not shown). One possibility to explain the anomalous migration and the multiple bands might be incomplete reduction of some or all of the nine Cys in xXPA (Fig. 1), even though fresh 5 mM DTT was present in all buffers during purification and 100 mM DTT was used in the SDS-PAGE loading buffer. To test whether the sulfhydryls are indeed in the reduced state prior to gel electrophoresis, we estimated free sulfhydryls using Ellman's reagent (Fig 2B). These data clearly show that all nine cysteines in xXPA are reduced under the conditions used to purify this protein. Lack of disulfides in xXPA is also consistent with our ESI-FTICR MS assignment, which precisely matched its expected mass.

Fig. 1.

Fig. 1.

Full-length Xenopus XPA sequence. The Zn finger (shaded) and poly-Glu domain (box) are indicated. Cys are boxed.

Fig. 2.

Fig. 2.

(A) SDS-PAGE of xXPA reveals aberrant mobility, even after iodoacetamide treatment. Five micrograms of purified xXPA in the absence (lane 1) and presence (lane 2) of iodoacetamide were resolved by 10% SDS-PAGE, as described in Materials and Methods. MWM (right), Broad Range Protein Markers, New England BioLabs. Mobility of intact xXPA after reaction with iodoacetamide corresponds to ∼42 kDa. (B) Determination of xXPA sulfyhydryl content with Ellman's reagent. Absorbance at 412 nm (x-axis) vs. indicated Cys standards (y-axis) yielded a linear fit. A 0.06 mM xXPA sample had 0.6892 absorbance at 412 nm that corresponds to 0.532 mM sulfhydryl, consistent with 9 reduced Cys in xXPA.

The Ellman's reagent data show that all sulfhydryls are reduced prior to electrophoresis, yet contributions from disulfide bonds cannot be completely eliminated. The environment within the gel is strongly oxidizing due to ammonium persulfate used for the gel polymerization and therefore could cause disulfide bond formation during SDS-PAGE (Bordini et al. 1999). To test this possibility, thioglycolate, a free-radical scavenger and antioxidant, included in the electrophoresis buffer at 0.1 mM and SDS-PAGE was prerun for 3 h before loading the samples. Thioglycolate addition did not reduce the number of bands on the gel and did not change the apparent molecular weight of xXPA (not shown).

To covalently modify xXPA's reduced SH groups (Hermanson 1996) and thereby prevent disulfide bonds formation during the electrophoresis, xXPA was alkylated with iodoacetamide. This treatment eliminated the multiple bands between ∼40–45 kDa (Fig 2A, lane 1), yielding a single band of ∼42 kDa (Fig 2A, lane 2), which remains far above xXPA's molecular weight. Thus, the sulfhydryl groups contribute to the alternative bands, but blocking them does not correct the aberrant mobility.

The calculated and SDS-PAGE-determined molecular weights for most unmodified proteins agree within ±5%, presumably due to charge and shape compensation involving differential SDS binding (Dunker and Rueckert 1969). The 40% divergence between calculated and observed sizes for xXPA falls several standard deviations outside the norm and it is consistent with other examples for anomalous migration (e.g., Klenova et al. 1997). Aberrant migration on SDS-PAGE for recombinant fibrinogen fragments sometimes exceeds 400% due to a high incidence of an unusual α-helical coiled-coil structure (Query et al. 1989). For other proteins, abnormal mobility (≤160%) sometimes results from localized regions of high charge (Query et al. 1989). xXPA's Glu-rich region (EEEEAEE) between 70–76 therefore might be a potential explanation for aberrant mobility.

ESI-FTICR MS identification of aberrantly migrating fragments

A protein's migration anomaly might be associated with one or just a few local sequence regions containing excess positive or negative charge. If so, one or a few peptide fragments would exhibit anomalous mobility, whereas the others would exhibit the usual mass/migration relationship. To evaluate whether particular regions in xXPA were responsible for its aberrant mobility, partial proteolysis fragments covering 100% of the protein sequence were separated by reverse-phase HPLC and then analyzed by both SDS-PAGE and ESI-FTICR mass spectrometry (Fig. 3, Table 1). SDS-PAGE lacks sufficient resolution to identify discrete proteolysis fragments, especially those of similar size. ESI-FTICR MS provides precise mass determinations of individual fragments within complex mixtures and deduction of the sequence corresponding to each fragment, even for polypeptides not well separated by SDS-PAGE.

Fig. 3.

Fig. 3.

Combined SDS-PAGE and ESI-FTICR mass spectrometry of fragments separated by reverse-phase HPLC. Partial proteolysis reactions were at 1:2000 (A) and 1:200 (w/w) (B) of trypsin:xXPA for 45 min. Lane 1, xXPA; lane 2, 45 min digestion at indicated trypsin concentration; lanes 38, reverse-phase chromatography fractions corresponding to indicated peaks; lane 9, Broad Range Protein Markers. Aliquots were separated by reverse-phase chromatography and recovered fractions were subjected to 10%–20% gradient Tris-glycine SDS-PAGE.

Table 1.

xXPA fragment identification by ESI-FTICR mass spectrometry, SDS-PAGE, and N-terminal sequencing

1:200 fractions 1:2000 fractions
Tryptic fragm. Calc molecular wt. Meas molecular wt. SDS-PAGE mob, kDa %, Δ gel vs. calc 46 47 48 59 60 61 47 48 49 60 61 62
40–220 21029.635 21029.303 27 28 X X
40–219 20873.533 20873.663 27 29 X X
40–216 20475.306 20475.506a 27 32 X X X
37–213 20475.244 27 32
40–214 20247.140 20247.222 27 33 X X
40–209 19600.759 19600.219 26 33 X X X
40–207 19344.606 19344.796 26 34 X X X X
60–207 17277.505 17277.055 23 33 X
60–205 17017.368 17017.510 23 35 X X
60–203 16774.246 16774.309 21 25 X X
60–199 16260.980 16261.010 21 29 X
85–207 14467.179 14467.193 16 11 X
85–205 14208.043 14208.006 16 13 X
85–203 13964.921 13964.932 16 15 X
85–199 13451.656 13451.659 16 19 X
224–265 4980.177 4980.180 7.6 53 X X X

The indicated reverse-phase chromatography fractions (Fig. 3) were analyzed by ESI-FTICR mass spectrometry. Fragments are listed in order of decreasing molecular weight. Fragments detected in each HPLC fraction are indicated by X, and those in bold were subjected to N-terminal sequencing as an independent verification of their identity. Observed and calculated masses represent monoisotopic molecular weight (fragments <15,000) or most abundant isotopic molecular weight (fragments ≥15,000). The column %Δ displays the percent difference between the observed ESI-FTICR molecular weight for a particular fragment and its molecular weight estimated by SDS-PAGE. The migration of the listed fragments was in the linear range relative to multiple molecular weight markers.

a Fragments 40–216 and 37–213 could not be distinguished because their calculated molecular weights differ by only 0.062 Da.

Resolving the proteolysis fragments by reverse-phase chromatography was unexpectedly difficult. Although 10%–20% Tris-glycine gradient gels showed ∼10 bands larger than 14 kDa and presumably many low molecular weight fragments (<14 kDa) were likely present, only two or three total peaks were found using several reverse-phase protocols (not shown). Nonresolving reverse-phase chromatography conditions included solubilizing samples in 6M guanidine-HCl (or 8M urea) ± 40–120 mM DTT followed by MeCN gradients in 0.1% TFA. Alternate ion pairs for TFA with increasing MeCN gradients, such as 10 mM ammonium acetate at pH 8.0 or 10 mM methylphosphonic acid at pH 6.5, 100 mM sodium perchlorate also failed to improve resolution. The most effective chromatography separations yielded only three to five well-resolved peaks, each of which contained multiple proteolysis fragments when the recovered fractions were analyzed by SDS-PAGE (Fig. 3, Table 1). Similarly poor resolution of partial proteolysis products with reverse-phase HPLC has been reported for other proteins, for example, stathmin (Redeker et al. 2000). Tryptic fragments separated by reverse-phase HPLC are listed in order of decreasing molecular weight in Table 1. Fourteen additional fragments below 4 kDa identified by ESI-FTICR MS were in the nonlinear range of the SDS-PAGE resolution (not shown). For each fragment, the ESI-FTICR mass spectrometry measured and calculated molecular weights agree extremely well. In contrast, the molecular weight estimated by SDS-PAGE diverged 11%–53% from the calculated molecular weight. Every analyzed fragment between ∼5–25 kDa revealed aberrant mobility, suggesting that the origin of the anomalous migration of xXPA is not localized to just one region.

Full-length xXPA's 40% deviation from the expected migration on SDS-PAGE becomes ∼30% for fragments without the first 40 N-terminal and the last 60 C-terminal amino acids (Table 1). This deviation falls even further to ∼15% for fragments confined to the ordered core (85 to ∼200) lacking the highly charged E70-E76 region. Moreover, the ordered core region in hXPA that comprises the minimal DNA-binding domain also migrates about ∼15% larger than expected (not shown). The xXPA C-terminal fragment exhibits the largest mobility difference between molecular weight on SDS-PAGE and that calculated from the sequence. This result is consistent with our findings that disordered regions display higher discrepancy in SDS-PAGE mobility. We conclude the cause for xXPA's aberrant mobility correlates primarily with both the highly charged Glu-rich region and with its large disordered terminal domains.

Glutaraldehyde crosslinking demonstrates intra- and intermolecular crosslinks

Modification of amines with glutaraldehyde results in both intra-and intermolecular crosslinks (Hermanson 1996). Addition of glutaraldehyde to ovalbumin control at 0.05% (v/v) did not change its SDS-PAGE mobility, yet the same glutaraldehyde concentration produced numerous apparent inter- (*) and intramolecular (♦) crosslinks in xXPA (Fig. 4). The gel shows more putative intermolecular crosslinks at lower glutaraldehyde concentrations (Fig. 4, lanes 67), perhaps because some intermolecular crosslinked oligomers failed to enter the gel. At 0.05% glutaraldehyde, most of the xXPA aggregated at the top of the gel. The discrete patterns of intramolecular crosslinked products indicate there are preferred sites for glutaraldehyde reactivity. Precise identification of these sites would yield structural insights into full-length XPA, whose known structure is limited to only a minimal DNA-binding domain (Buchko et al. 1998; Ikegami et al. 1998). Interestingly, the intramolecular crosslinks produced a monomeric xXPA that migrated closer to its expected molecular weight of 31 kDa. Denaturing with SDS generates an open, unconstrained protein structure that generally provides accurate mass assignment on SDS-PAGE. Intramolecular crosslinking constrains protein structure, thereby preventing complete unfolding by SDS and would be expected to yield inaccurate mass assignments by SDS-PAGE. Our results show that intramolecular crosslinking produced a more accurate assessment of xXPA's molecular weight by SDS-PAGE, that is, the exact opposite of the expected result and the first reported example for glutaraldehyde correcting an anomalous molecular weight. The more intramolecular crosslinks at higher glutaraldehyde concentrations, the closer xXPA migrates to its expected mobility (Fig. 4, lane 4 vs. 7). Up to 10-fold lower concentrations of glutaraldehyde yielded bands consistent with xXPA oligomers, although future experiments would be needed to identify these species.

Fig. 4.

Fig. 4.

Glutaraldehyde crosslinking of xXPA. Five micrograms of purified ovalbumin (lane 1) or xXPA (lane 3) were treated with glutaraldehyde and analyzed by SDS-gradient PAGE (4%–20%), as described in Materials and Methods. No crosslinks were observed for ovalbumin. Putative xXPA oligomers (*) were observed predominantly at low-glutaraldehyde concentrations. Several bands (♦) between 30–40 kDa consistent with intramolecular crosslinks were observed at higher glutaraldehyde concentrations. MWM as described in the Fig. 1 legend. Glutaraldehyde concentrations (% v/v) for lanes 28 were 0, 0.05, 0.05, 0.02, 0.01, 0.005, and 0, respectively.

For typical globular proteins, which become highly extended upon forming complexes with SDS (Reynolds and Tanford 1970), introduction of crosslinks causes decrease in hydrodynamic radius and SDS binding (Pitt-Rivers and Impiombato 1968), and consequently an overall decrease in net charge. Usually crosslinking causes only small changes in mobility because the combination of these effects nearly cancel (Dunker and Rueckert 1969; Dunker and Kenyon 1976). The large mobility shift of xXPA after glutaraldehyde crosslinking suggests that a reduction in hydrodynamic radius is likely not accompanied by a significant decrease in SDS binding.

The crosslinking results on xXPA can be evaluated in terms of current models for protein mobility in SDS-PAGE. The necklace model for SDS-protein complexes was based on studies showing that, in the absence of gel, SDS-protein complexes migrate irrespective of their size. This model, in which micelles are distributed along the partially folded peptide chain (Shirahama et al. 1974) was confirmed by direct visualization using cryo-electron microscopy (Samso et al. 1995). The sieving effects of gels presumably facilitate the separation of proteins according to their size. Combining the necklace and sieving models (Westerhuis et al. 2000) can describe the electrophoretic behavior of the SDS-protein complexes on gels. The increased mobility of xXPA following glutaraldehyde crosslinking can be explained by these electrophoretic models assuming that the extended, intrinsically disordered regions of xXPA are not covered by SDS micelles, as are the polypeptide chains of globular proteins. Because intrinsically unstructured protein regions lack hydrophobic clusters sufficient to induce folding, they might also be unable to nucleate SDS micelle formation. Thus the collapse caused by glutaraldehyde crosslinking is not compensated by reduced SDS binding. These conjectures to explain xXPA's aberrant electrophoretic mobility suggest that proteins with intrinsically unstructured regions of sufficient size would frequently migrate anomalously in SDS-PAGE.

Aberrant behavior on gel filtration chromatography

The molecular parameters influencing apparent molecular weight on gel filtration and SDS-PAGE are size, shape, and charge of the molecule (Hollecker 1997). Correlating molecular weight into a measure of size is influenced by hydration, partial specific volume, and protein geometry (e.g., flexible or random coils, spheroid, ellipsoid, etc.). The charge density and free mobility depend on the amount of bound SDS (Poduslo and Rodbard 1980), which preferentially interacts with basic or hydrophobic amino acids. The overall composition of xXPA reflects comparable percentages of nonpolar, polar, acidic, and basic amino acids. Furthermore, the composition of disordered N and C termini and the ordered core do not significantly differ from that of the full-length molecule (Table 2). Thus the overall charge and hydrophobicity of xXPA do not necessarily imply unusual SDS mobility, with the exception of the E70–E76 region.

Table 2.

Summary of amino acid composition of xXPA and its subdomains

xXPA domains Amino acid positions Nonpolar (%) Polar (%) Acidic (%) Basic (%)
N terminus M1-R84 41.65 21.42 20.24 16.66
C terminus K180-M265 23.25 26.76 22.09 27.91
xXPA core Q85-I179 35.79 26.33 18.95 18.95
Full-length xXPA M1-M265 33.58 24.92 20.38 21.14

In order to determine if disordered domains in native xXPA contribute to unusual hydrodynamic properties, we performed size-exclusion chromatography under nondenaturing conditions. Fluorescence binding experiments show that xXPA binds DNA as a monomer (L.M. Iakoucheva et al., submitted), yet its apparent molecular weight estimated by gel filtration chromatography was 92 kDa (Fig. 5). Gel filtration chromatography is moderately accurate if the protein is roughly the same shape as the standards used to calibrate the column (Deutscher 1990). Aggregation of samples on the column is an unlikely cause for the ∼300% higher apparent molecular weight than expected because there is a linear relationship between log molecular weight and Kav (Fig. 5A) for the protein standards and a very symmetrical shape for the xXPA elution profile (Fig. 5B). It is also unlikely that xXPA's aberrantly large size estimated by gel filtration chromatography is due to binding the column matrix because the column-independent Kav is <1; this is a good indicator that interaction with the matrix is minimal (Deutscher 1990). Furthermore, the same molecular weight was observed at different flow rates and in a different buffer (see Materials and Methods), as well as when using a different matrix, i.e., Pharmacia Superdex 200 (not shown) rather than Pharmacia Superose 12. We conclude that xXPA under native conditions has an unusually extended shape, which can contribute to its aberrant behavior during gel filtration chromatography. An abnormally high apparent molecular weight by gel exclusion has been used as an indicator for intrinsically unfolded protein (Kriwacki et al. 1997).

Fig. 5.

Fig. 5.

Gel filtration chromatography of xXPA. (A) Two hundred fifty micrograms of purified xXPA yielded a calculated molecular weight of 92 kDa with an r2 of 0.973 based on the following known standards: aldolase (158 kDa), albumin (67 kDa), ovalbumin (43 kDa), chymotrypsinogen (25 kDa), and ribonuclease A (13.7 kDa). (B) Elution profile of the xXPA revealed a single symmetrical peak with no detectable aggregation.

XPA-DNA interactions investigated by gel filtration chromatography

The conserved disordered regions that constitute about two-thirds of XPA likely provide essential functional role(s) in DNA damage recognition and interaction with other proteins. Conformational changes in the disordered regions upon DNA and protein binding could alter XPA's hydrodynamic properties. Here we determine whether xXPA binding to DNA significantly alters its apparent molecular weight on gel filtration chromatography under native conditions (Fig. 6).

Fig. 6.

Fig. 6.

Gel filtration chromatography of xXPA–DNA complexes. 3.5 nM xXPA and a 0.4 nM 20-mer oligonucleotide ± a single cisplatin were subjected to gel filtration chromatography, as described in Materials and Methods. (A) Elution profiles for the xXPA with undamaged DNA show two major peaks consistent with xXPA–DNA complex (▪) and free DNA (•). (B) Elution profiles for the xXPA with cisplatin DNA show a major peak consistent with xXPA-cisplatin DNA complex (□) and a minor peak that contains cisplatin DNA (○). (C) Native gel demonstrating peak assignments for ▪, •, □, and ○. Complexes, oligonucleotide substrates ± mismatches ± cisplatin, and electophoresis were as described in Materials and Methods. Lanes 1, 3, 6, 7, 9, and 11 are peak fractions corresponding to xXPA–DNA complexes (retention time ∼24.8 min); lanes 2, 4, 6, 8, 10, and 12 are peak fractions corresponding to unbound DNA (retention time ∼27.6 min). The native PAGE was stained with SYBR Green I.

DNA substrates were oligonucleotides (20-mers) containing a single defined cis-diamminedichloro-platinum(II) (cisplatin) lesion and 0, 2, or 4 mismatches opposite the cisplatin (see Materials and Methods). The gel filtration column has sufficient resolving power to separate unbound DNA and xXPA because their elution times differ by 2 to 3 min. Potentially it can also resolve the xXPA-DNA complexes, provided they do not overlap with the free DNA or xXPA. We found the xXPA-DNA complexes containing either undamaged DNA (Fig. 6A, ▪) or cisplatin DNA (Fig. 6B, □) were sufficiently stable to withstand gel filtration chromatography. Previous reports showed XPA has only a two- to threefold preference for damaged DNA (Jones and Wood 1993; Asahina et al. 1994; Lao et al. 2000). Our data demonstrates significantly more complex (at least 10-fold) forms with the cisplatin substrate as shown by disappearance of the free DNA peak from the chromatographic profiles (Fig. 6A,B, • vs. ○) and by densitometric analysis of an electrophoretic mobility shift assay (EMSA; Fig. 6C) of chromatographic fractions. This analysis confirms peak assignments and indicates good recovery of both DNA and protein after chromatography. Nearly all (∼80%) of the cisplatin DNA is present in the complex, whereas only ∼5% of the undamaged DNA is bound to xXPA. This means that xXPA–(cisplatin) DNA complex either forms more readily and/or is more stable to gel filtration chromatography than the xXPA–(undamaged) DNA complex, as expected for a DNA-damage-recognition protein. Thus xXPA exhibits at least two DNA-binding modes and DNA with damage is preferred to undamaged DNA. Our results indicate that gel filtration chromatography is a sensitive assay to investigate xXPA–DNA interactions.

Previous studies showed that enhanced NER occurred at sites that contained both cisplatin adducts and mismatches (Moggs et al. 1997) or both cyclobutane pyrimidine dimers and mismatches (Mu et al. 1997). However, distortion to DNA without a covalent modification is insufficient for NER because small loops and mismatches are repaired very poorly, if at all (Hess et al. 1997; Moggs et al. 1997; Mu et al. 1997); although one recent EMSA analysis showed preferential binding of hXPA to 19-mer DNA containing three mismatches (Buschta-Hedayat et al. 1999). Consistent with the NER studies, our gel filtration results show that xXPA can not discriminate between undamaged DNA and DNA with two to four mismatches (Fig. 6C, lanes 16). Furthermore, xXPA can not discriminate between cisplatin DNA with mismatches and cisplatin DNA without mismatches (Fig. 6C, lanes 712). Complexes containing DNA with TT mismatches opposite the cisplatin-GG, or TTTT mismatches opposite the T(cisplatin)GGT showed about the same amount of bound DNA that was still 10 times higher than in complexes with undamaged DNA ± mismatches.

Next we investigated whether xXPA binding to DNA significantly alters its apparent molecular weight. Binding to DNA ± damage results in a single symmetrical peak. The elution position of the complex corresponds to ∼100 kD (Fig. 5A), which is about three times its expected size. Thus, DNA binding does not cause a conformational change that significantly alters xXPA's 92-kD anomalous migration on gel filtration chromatography.

Is there a correlation between our disorder/order data and known mutations in XP patients? There are several known mutations in introns and missense mutations affecting hXPA splice sites, but nearly all reported coding-region point mutations are located in the ordered minimal DNA binding domain, especially in the Zn-finger region. The nearest N-terminal mutation (L94 to P94) is at the boundary between the disordered domain and the ordered MBD. Nonmissense, coding-region mutations on the C-terminal side of the MBD include only a single reported substitution, H244 to R244 (States et al. 1998). Thus the clinical cases reveal that amino acid mutations in both the intrinsically disordered N- and C-terminal domains occur rarely, if ever, while point mutations, insertions, deletions, and missense mutations are clustered in the ordered domain. Further analyses of mutation rates in ordered versus disordered regions are needed to determine the significance of this observation.

In summary, both native xXPA ± DNA on gel filtration chromatography and xXPA on SDS-PAGE exhibit aberrantly large migration behavior. The causes for this phenomena, as determined by SDS-PAGE, are not restricted only to the highly charged Glu-rich region, but are also related to the protein's unusual shape derived mainly from its disordered N- and C-terminal domains. These disordered regions are highly conserved in five species (Iakoucheva et al. 2001) and probably relate to XPA's functional roles in DNA damage recognition and repair. Intramolecular crosslinks at defined locations partially correct xXPA's aberrant mobility. Identifying crosslink sites in proteins and complexes by ESI-FTICR MS will provide a new assay to probe interactions, particularly for disordered domains that are difficult to study by NMR or crystallography. This approach could complement site-specific hydrogen exchange studies to map disorder and conformational changes (Nettleton and Robinson 1999). DNA binding does not significantly change xXPA's anomalous behavior on gel filtration chromatography under native conditions. However, gel filtration revealed greater preference by xXPA for DNA-containing lesions than previous studies. Further experiments with additional repair proteins ± DNA may be necessary to reveal conformational changes that correct its migration.

Materials and methods

Reagents

Sequencing-grade trypsin was purchased from Boehringer Mannheim, dissolved in 1mM HCl at 1 mg/mL, and used immediately. xXPA was prepared as previously described (Buchko et al. 1999) and shown to be active by functional assays (Ackerman and Iakoucheva 2000) in efficient Xenopus NER extracts (Oda et al. 1996). Further evidence of activity was confirmed by fluorescence spectroscopy studies showing that xXPA has a nanomolar-binding constant to DNA (L.M. Iakoucheva et al., in prep.).

Ioadacetamide reaction

After xXPA purification and concentration, freshly prepared DTT was added to a final concentration of 10 mM and incubated at 50°C for 10 min. After cooling to room temperature, iodoacetamide was added to a final concentration of 25 mM, incubated for 15 min in the dark at room temperature, and loaded on 10% SDS-PAGE in the SDS-loading buffer containing fresh 100 mM DTT.

Reverse-phase chromatography

Limited proteolysis of xXPA, analysis by ESI-FTICR and SDS-PAGE were as previously described (Iakoucheva et al. 2001). After limited proteolysis, the fragments were solubilized by the addition of guanidine HCl to 6 M, and DTT to 120 mM; 100 μL samples were boiled 3 min; then 400 μL 6% acetonitrile/0.1% trifluoroacetic acid was added immediately and samples were loaded directly onto a Vydac C4 214MS5215 column equilibrated in 0.1% TFA and 5% MeCN. The column was washed with 10-column volumes (CV) of 5% MeCN to remove excess salts and then consecutive gradients of 5–15% MeCN (1.5 CV) at 2.5%/min, 15–42.5% MeCN (11 CV) at 1%/min, and 42.5–55% acetonitrile (2 CV) at 2.5%/min were run. All column buffers contained 0.1% TFA. Fractions were taken at 1 min intervals and aliquots were analyzed by SDS-PAGE and by ESI-FTICR mass spectrometry. This approach allowed a better comparison of the SDS-PAGE mobility with the measured masses of the fragments since aliquots of the same fraction were used in both experiments.

Electrophoresis

Limited proteolysis reactions were terminated by boiling 5 min in SDS-PAGE loading buffer containing 100 mM DTT. The 10% and 16% Tris-glycine gels were prepared as described (Laemmli 1970) and all other gels were purchased from Novex.

Determination of sulfhydryl content with Ellman's reagent

Ellman's reagent and Cysteine standards were purchased from Pierce and used according to the manufacturer's instructions. The concentration of purified recombinant xXPA was determined using the molar extinction coefficient of 29,940 calculated according to Mach et al. (1992). The sulfhydryl concentration in xXPA was determined from the calibration curve obtained for the Cysteine standards.

Gel-filtration chromatography

Gel-filtration Superose 12 HR 10/30 column was purchased from Pharmacia. The column was equilibrated overnight in 0.5M NH4OAc at pH 7.5 (Buffer A). Similar results were obtained when using the same column in 25mM HEPES-KOH at pH 7.5, 200mM KCl, 5mM MgCl2, 5mM DTT (Buffer B). For accurate determination of xXPA molecular weight, the High and Low Molecular Weight Gel Filtration Calibration Kits (Pharmacia) were used for preparation of the calibration curve, as described by the manufacturer. The elution volumes of the standards were determined and then xXPA (250 μg) was loaded. Kav for xXPA was calculated using formula Inline graphic, where Ve, elution volume for the protein; V0, column void volume; Vt, total bed volume. xXPA MW was estimated from the calibration curve. For forming xXPA–DNA complexes the binding of 120 μg xXPA to 5 μg DNA was performed in (Buffer B), the mixture was incubated for 30 min at 30°C and loaded on the gel filtration column.

Glutaraldehyde crosslinking

Twenty-five percent aqueous solution of glutaraldehyde was purchased from Sigma. The concentrated xXPA was dissolved in 10 mM NaPi at pH 7.5, 150mM NaCl (30 μL reaction volume, 5 μg of xXPA per reaction) and glutaraldehyde was added to final concentrations of 0.05%, 0.02%, 0.01%, and 0.005%. The mixture was incubated for 30 min at 25°C, the SDS-loading buffer containing 100 mM DTT was added and the samples were boiled 3 min and loaded on the gradient 4%–20% SDS-PAGE.

N-terminal sequencing

Limited proteolysis reactions were electrophoresed on glycine-free SDS-PAGE, 4%–12% Bis-Tris gel (Novex) and electroblotted onto PVDF membrane (Moos 1998). N-terminal sequencing was done in the Laboratory for Bioanalysis and Biotechnology, Unit 1, at Washington State University on an Applied Biosystem 475A according to manufacturer's instructions.

DNA substrates and EMSA

Oligonucleotide used for the XPA-DNA binding studies were as follows:

  1. 5′-CTTCTTCTGGTCTTCTCTTC-3′

    3′-GAAGAAGACCAGAAGAGAAG-5′

  2. 5′-CTTCTTCTGGTCTTCTCTTC-3′

    3′-GAAGAAGATTAGAAGAGAAG-5′

  3. 5′-CTTCTTCTGGTCTTCTCTTC-3′

    3′-GAAGAAGTTTTGAAGAGAAG-5′

  4. Pt

    5′-CTTCTTCTGGTCTTCTCTTC-3′

    3′-GAAGAAGACCAGAAGAGAAG-5′

  5. Pt

    5′-CTTCTTCTGGTCTTCTCTTC-3′

    3′-GAAGAAGATTAGAAGAGAAG-5′

  6. Pt

    5′-CTTCTTCTGGTCTTCTCTTC-3′

    3′-GAAGAAGTTTTGAAGAGAAG-5′

ESI-FTICR MS confirmed a single cisplatin in each oligonucleotide (Xu et al. 1999). Binding conditions in Buffer B were as described for gel filtration, and the peaks corresponding to xXPA–DNA complexes and free DNA were collected and electrophoresed on 8% native polyacrylamide gel in 0.5 X TAE with addition of 0.5mM MgCl2 (both in gel and running buffers) at 10V/cm for ∼2 h in the cold (4°C). The bands were visualized by staining the gel with SYBR Green (Molecular Probes) according to manufacturer's instructions. The amount of DNA in each band was quantitated using NIH Image.

Acknowledgments

This work was supported by the Laboratory Directed Research and Development program of Pacific Northwest National Laboratory operated by Battelle for the U.S. Department of Energy.

The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.

Abbreviations

  • cisplatin, Cis-diamminedichloro-platinum(II)

  • EMSA, electrophoretic mobility shift assay

  • ESI-FTICR MS, electrospray ionization interface coupled to a Fourier transform ion cyclotron resonance mass spectrometry

  • XPA, Xeroderma pigmentosum group A

Article and publication are at www.proteinscience.org/cgi/doi/10.1110/ps.40101.

References

  1. Ackerman, E.J. and Iakoucheva, L.M. 2000. Nucleotide excision repair in oocyte nuclear extracts from Xenopus laevis. In Methods: A Companion to Methods in Enzymology. 22 188–193. [DOI] [PubMed] [Google Scholar]
  2. Armstrong, D.J. and Roman, A. 1993. The anomalous electrophoretic behavior of the human papillomavirus type 16 E7 protein is due to the high content of acidic amino acid residues. Biochem. Biophys. Res. Commun. 192 1380–1387. [DOI] [PubMed] [Google Scholar]
  3. Asahina, H., Kuraoka, I., Shirakawa, M., Morita, E.H., Miura, N., Miyamoto, I., Ohtsuka, E., Okada, Y., and Tanaka, K. 1994. The XPA protein is a zinc metalloprotein with an ability to recognize various kinds of DNA damage. Mutat. Res. 315 229–237. [DOI] [PubMed] [Google Scholar]
  4. Billings, P.C., Orf, J.W., Palmer, D.K., Talmage, D.A., Pan, C.G., and Blumenfeld, M. 1979. Anomalous electrophoretic mobility of Drosophila phosphorylated H1 histone: Is it related to the compaction of satellite DNA into heterochromatin? Nucleic Acids Res. 6 2151–2164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bordini, E., Hamdan, M., and Righetti, P.G. 1999. Probing the reactivity of S-S bridges to acrylamide in some proteins under high pH conditions by matrix-assisted laser desorption/ ionisation. Rapid Commun. Mass Spectrom. 13 1818–1827. [DOI] [PubMed] [Google Scholar]
  6. Buchko, G.W., Ni, S., Thrall, B.D., and Kennedy, M.A. 1998. Structural features of the minimal DNA binding domain (M98-F219) of human nucleotide excision repair protein XPA. Nucleic Acids Res. 26 2779–2788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Buchko, G.W., Iakoucheva, L.M., Kennedy, M.A., Ackerman, E.J., and Hess, N.J. 1999. Extended X-ray absorption fine structure evidence for a single metal binding domain in Xenopus laevis nucleotide excision repair protein XPA. Biochem. Biophys. Res. Commun. 254 109–113. [DOI] [PubMed] [Google Scholar]
  8. Buschta-Hedayat, N., Buterin, T., Hess, M.T., Missura, M., and Naegeli, H. 1999. Recognition of nonhybridizing base pairs during nucleotide excision repair of DNA. Proc. Natl. Acad. Sci. 96 6090–6095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Deutscher, M.P. 1990. Guide to protein purification. In Methods in Enzymology, pp. 894. Academic Press, San Diego.
  10. Dunker, A.K. and Kenyon, A.J. 1976. Mobility of sodium dodecyl sulphate–protein complexes. Biochem. J. 153 191–197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dunker, A.K. and Rueckert, R.R. 1969. Observations on molecular weight determinations on polyacrylamide gel. J. Biol. Chem. 244 5074–5080. [PubMed] [Google Scholar]
  12. Fontana, A., Zambonin, M., Polverino de Laureto, P., De Filippis, V., Clementi, A., and Scaramella, E. 1997. Probing the conformational state of apomyoglobin by limited proteolysis. J. Mol. Biol. 266 223–230. [DOI] [PubMed] [Google Scholar]
  13. Friedberg, E.C., Walker, G.C., and Siede, W. 1995. DNA Repair and Mutagenesis. American Society of Microbiology, Washington, D.C.
  14. Hermanson, G.T. 1996. Bioconjugate Techniques. Academic Press, New York.
  15. Hess, M.T., Schwitter, U., Petretta, M., Giese, B., and Naegeli, H. 1997. Bipartite substrate discrimination by human nucleotide excision repair. Proc. Natl. Acad. Sci. 94 6664–6669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hollecker, M. 1997. Counting integral numbers of residues by chemical modification. In Protein Structure: A practical approach (ed. T.E. Creighton), pp. 151–164. IRL Press, Oxford.
  17. Hu, C.C. and Ghabrial, S.A. 1995. The conserved, hydrophilic and arginine-rich N-terminal domain of cucumovirus coat proteins contributes to their anomalous electrophoretic mobilities in sodium dodecylsulfate-polyacrylamide gels. J. Virol. Meth. 55 367–379. [DOI] [PubMed] [Google Scholar]
  18. Iakoucheva, L.M., Kimzey, A.L., Masselon, C.D., Bruce, J.E., Garner, E.C., Brown, C.J., Dunker, A.K., Smith, R.D., and Ackerman, E.J. 2001. Identification of intrinsic order and disorder in the DNA repair protein XPA. Prot. Sci. 10 560–571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ikegami, T., Kuraoka, I., Saijo, M., Kodo, N., Kyogoku, Y., Morikawa, K., Tanaka, K., and Shirakawa, M. 1998. Solution structure of the DNA- and RPA-binding domain of the human repair factor XPA. Nat. Struct. Biol. 5 701–706. [DOI] [PubMed] [Google Scholar]
  20. Jones, C.J. and Wood, R.D. 1993. Preferential binding of the xeroderma pigmentosum group A complementing protein to damaged DNA. Biochemistry 32 12096–12104. [DOI] [PubMed] [Google Scholar]
  21. Klenova, E.M., Nicolas, R.H., U, S., Carne, A.F., Lee, R.E., Lobanenkov, V.V., and Goodwin, G.H. 1997. Molecular weight abnormalities of the CTCF transcription factor: CTCF migrates aberrantly in SDS-PAGE and the size of the expressed protein is affected by the UTRs and sequences within the coding region of the CTCF gene. Nucleic Acids Res. 25 466–474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kriwacki, R.W., Hengst, L., Tennant, L., Reed, S.I., and Wright, P.E. 1996. Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: Conformational disorder mediates binding diversity. Proc. Natl. Acad. Sci. 93 11504–11509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kriwacki, R.W., Wu, J., Tennant, L., Wright, P.E., and Siuzdak, G. 1997. Probing protein structure using biochemical and biophysical methods. Proteolysis, matrix-assisted laser desorption/ionization mass spectrometry, high-performance liquid chromatography and size-exclusion chromatography of p21Waf1/Cip1/Sdi1. J. Chromatogr. A. 777 23–30. [DOI] [PubMed] [Google Scholar]
  24. Kuraoka, I., Morita, E.H., Saijo, M., Matsuda, T., Morikawa, K., Shirakawa, M., and Tanaka, K. 1996. Identification of a damaged-DNA binding domain of the XPA protein. Mutat. Res. 362 87–95. [DOI] [PubMed] [Google Scholar]
  25. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 680–685. [DOI] [PubMed] [Google Scholar]
  26. Lao, Y., Gomes, X.V., Ren, Y., Taylor, J.S., and Wold, M.S. 2000. Replication protein A interactions with DNA. III. Molecular basis of recognition of damaged DNA. Biochemistry 39 850–859. [DOI] [PubMed] [Google Scholar]
  27. Lindahl, T. and Wood, R.D. 1999. Quality control by DNA repair. Science 286 1897–1905. [DOI] [PubMed] [Google Scholar]
  28. Mach, H., Middaugh, C.R., and Lewis, R.V. 1992. Statistical determination of the average values of the extinction coefficients of tryptophan and tyrosine in native proteins. Anal. Biochem. 200 74–80. [DOI] [PubMed] [Google Scholar]
  29. Marciani, D.J. and Papamatheakis, J.D. 1978. Anomalous behavior of the major avian myeloblastosis virus glycoprotein in the presence of sodium dodecyl sulfate. J. Virol. 26 825–827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Miyamoto, I., Miura, N., Niwa, H., Miyazaki, J., and Tanaka, K. 1992. Mutational analysis of the structure and function of the xeroderma pigmentosum group A complementing protein. Identification of essential domains for nuclear localization and DNA excision repair. J. Biol. Chem. 267 12182–12187. [PubMed] [Google Scholar]
  31. Moggs, J.G., Szymkowski, D.E., Yamada, M., Karran, P., and Wood, R.D. 1997. Differential human nucleotide excision repair of paired and mispaired cisplatin–DNA adducts. Nucleic Acids Res. 25 480–491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Moos, M. 1998. Isolation of proteins for microsequence analysis. In Current Protocols in Molecular Biology (eds. F. Ausubel et al.), pp. 10.19.11-10.19.19. John Wiley and Sons, New York. [DOI] [PubMed]
  33. Mu, D., Tursun, M., Duckett, D.R., Drummond, J.T., Modrich, P., and Sancar, A. 1997. Recognition and repair of compound DNA lesions (base damage and mismatch) by human mismatch repair and excision repair systems. Mol. Cell Biol. 17 760–769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Nettleton, E.J. and Robinson, C.V. 1999. Probing conformations of amyloidogenic proteins by hydrogen exchange and mass spectrometry. Meth. Enzymol. 309 633–646. [DOI] [PubMed] [Google Scholar]
  35. Oda, N., Saxena, J.K., Jenkins, T.M., Prasad, R., Wilson, S.H., and Ackerman, E.J. 1996. DNA polymerases a and b are required for DNA repair in an efficient nuclear extract from Xenopus oocytes. J. Biol. Chem. 271 13816–13820. [DOI] [PubMed] [Google Scholar]
  36. Pitt-Rivers, R. and Impiombato, F.S. 1968. The binding of sodium dodecyl sulphate to various proteins. Biochem. J. 109 825–830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Poduslo, J.F. and Rodbard, D. 1980. Molecular weight estimation using sodium dodecyl sulfate—pore gradient electrophoresis. Anal. Biochem. 101 394–406. [DOI] [PubMed] [Google Scholar]
  38. Query, C.C., Bentley, R.C., and Keene, J.D. 1989. A common RNA recognition motif identified within a defined U1 RNA binding domain of the 70K U1 snRNP protein. Cell 57 89–101. [DOI] [PubMed] [Google Scholar]
  39. Redeker, V., Lachkar, S., Siavoshian, S., Charbaut, E., Rossier, J., Sobel, A., and Curmi, P.A. 2000. Probing the Native Structure of Stathmin and Its Interaction Domains with Tubulin. Combined use of limited proteolysis, size exclusion chromatography, and mass spectrometry. J. Biol. Chem. 275 6841–6849. [DOI] [PubMed] [Google Scholar]
  40. Reynolds, J.A. and Tanford, C. 1970. The gross conformation of protein-sodium dodecyl sulfate complexes. J. Biol. Chem. 245 5161–5165. [PubMed] [Google Scholar]
  41. Samso, M., Daban, J.R., Hansen, S., and Jones, G.R. 1995. Evidence for sodium dodecyl sulfate/protein complexes adopting a necklace structure. Eur. J. Biochem. 232 818–824. [PubMed] [Google Scholar]
  42. Shirahama, K., Tsujii, K., and Takagi, T. 1974. Free-boundary electrophoresis of sodium dodecyl sulfate–protein polypeptide complexes with special reference to SDS-polyacrylamide gel electrophoresis. J. Biochem. 75 309–319. [DOI] [PubMed] [Google Scholar]
  43. States, J.C., McDuffie, E.R., Myrand, S.P., McDowell, M., and Cleaver, J.E. 1998. Distribution of mutations in the human xeroderma pigmentosum group A gene and their relationships to the functional regions of the DNA damage recognition protein. Hum. Mutat. 12 103–113. [DOI] [PubMed] [Google Scholar]
  44. Westerhuis, W.H., Sturgis, J.N., and Niederman, R.A. 2000. Reevaluation of the electrophoretic migration behavior of soluble globular proteins in the native and detergent-denatured states in polyacrylamide gels. Anal. Biochem. 284 143–152. [DOI] [PubMed] [Google Scholar]
  45. Wright, P.E. and Dyson, H.J. 1999. Intrinsically unstructured proteins: Re-assessing the protein structure–function paradigm. J. Mol. Biol. 293 321–331. [DOI] [PubMed] [Google Scholar]
  46. Xu, N., Pasa-Tolic, L., Smith, R.D., Ni, S., and Thrall, B.D. 1999. Electrospray ionization–mass spectrometry study of the interaction of cisplatin-adducted oligonucleotides with human XPA minimal binding domain protein. Anal. Biochem. 272 26–33. [DOI] [PubMed] [Google Scholar]

Articles from Protein Science : A Publication of the Protein Society are provided here courtesy of The Protein Society

RESOURCES